Transforming Pharmacological Research: Utilizing AI and Machine Learning in Drug Discovery and Development
In the past few years, the application of artificial intelligence (AI) in health systems has risen continuously. The rapid advancement of AI has revolutionized the area of experimental pharmacology and drug discovery. It enables efficient analysis of vast datasets, aids in drug discovery to real-world data mining, enhances predictive modeling, accelerates the recognition of probable drug candidates, optimizes drug design and helps in target identification. Furthermore, algorithms for machine learning can examine complex biological interactions and offer insightful information about drug mechanisms and toxicity. Integrating AI into pharmacology research not only accelerates the process of developing drugs but also contributes to more precise and effective therapeutic interventions. In post-marketing inspection/ pharmacovigilance, AI is used to observe adverse drug reactions, find out drug interactions, design clinical research, and contribute to pharmacovigilance efforts by applying its different AI-based tools. Machine learning (ML) models extract patterns from complex data records, produce correct results and help in resolution, because of their potential to accelerate drug discovery. In this investigation, we will discuss the basics of AI, innovative research and development in AI methods followed by the benefits of AI in pharmacology research as well as clinical practice. This study will demonstrate AI and ML-driven key challenges in the advancements of therapeutic development and drug discovery.
Authors
- Mamta Joshi (ORCID: https://orcid.org/0000-0002-8449-3898)
- Sushma Tiwari (ORCID: https://orcid.org/0000-0003-0555-1840)
- Garima Chand
- Amit Mittal (ORCID: https://orcid.org/0000-0001-9689-1642)
- Pradeep Kumar Sharma (ORCID: https://orcid.org/0000-0002-7337-9993)
- Jyoti Gwasikoti
Institutions
- Graphic Era University (IN)
Publication Details
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1109/icssas64001.2024.10760304
- Citations
- 3
- Primary Topic
- Genetics, Bioinformatics, and Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.70